An 8-week, double-blind, flexible-dose trial comparing low doses of clomipramine (mean=50 mg) with moderate doses of imipramine (mean=113.8 mg and propanteline (active placebo), was carried out in 60 out-patients with panic disorder with or without agoraphobia. Efficacy evaluation included global, anxiety and depression rating scales, and the determination of rates of relapse over up to 10 weeks of single-blind placebo follow-up. Both tricyclics were significantly more effective than propanteline, but clomipramine tended to act faster and more consistently than imipramine on most measures. Given the degree of blindness achieved and the significantly lower doses of clomipramine, this seems a better reference drug than imipramine for clinical trials in panic/agoraphobia.
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn, Revised. American Psychiatric Press , Washington.
2.
Aronson T.A. (1987) A naturalistic study of imipramine in panic disorder and agoraphobia. Am J Psychiatr144: 1014-1019
3.
Baldessarini R.J. (1985) Chemotherapy in psychiatry. Principles and practice . Harvard University Press, Cambridge, MA
4.
Ballenger J.C., Burrows G.D., DuPont R.L. Jr, Lesser I.M., Noyes R. Jr, Pecknold J.C., Rifkin A., Swinson R.P. (1988) Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. Arch Gen Psychiatr45: 413-422
5.
Beck A.T., Steer R.A., Garbin M.G. (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev8: 77-100
6.
Beck A.T., Ward C., Mendelson M., Mock J., Erbaugh J. (1961) An inventory for measuring depression. Arch Gen Psychiatr4: 561-571
7.
Cassano G.B., Petracca A., Perugi G., Nisita C., Musetti L., Mengali F., McNair D.M. (1988) Clomipramine for panic disorder: I. The first 10 weeks of a long-term comparison with imipramine. J Affective Disord14: 123-127
8.
Coryell W.D., Noyes R. (1988) Placebo response in panic disorder. Am J Psychiatr145: 1138-1140
9.
Dager S.R., Khan A., Cowley D., Avery D.H., Elder J., Roy-Byrne P., Dunner DL (1990) Characteristics of placebo response during long-term treatment of panic disorder. Psychopharmacol Bull26: 273-278
10.
Deakin J F W, Graeff F.G. (1991) 5-HT and mechanisms of defense. J Psychopharmacol5: 305-315
11.
Den Boer J.A., Westenberg H G M (1988) Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol3: 59-74
12.
Den Boer J.A., Westenberg H G M, Kamerbeek W D J, Verhoeven W M A, Kahn R.S. (1987) Effect of serotonin uptake inhibitors in anxiety disorders: a double-blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacol2: 21-32
13.
Evans L., Kenardy J., Schneider P., Hoey H. ( 1986) Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo. Acta Psychiatr Scand73: 49-53
14.
Gentil V. (1986) Fisiopatologia da sindrome do pânico. Rev Assoc Med Brasil, 32: 101-107
15.
Gentil V. (1988) The aversive system, 5 HT and panic attacks. In Simon P, Soubrié P, Widlocher D (eds), Selected models of anxiety, depression and psychosis. Animal models of psychiatric disorders, vol. 1., Karger, Basel, pp. 142-145
16.
Gloger S., Grunhaus L., Birmacher B., Troudart T. (1981) Treatment of spontaneous panic attacks with chlomipramine . Am J Psychiatr138: 1215-1217
17.
Gloger S., Grunhaus L., Gladic D., O'Ryan F., Cohen L., Codner S. (1989) Panic attacks and agoraphobia: low dose clomipramine treatment. J Clin Psychopharmacol9: 28-32
18.
Gloger S., O'Ryan F., Franulic A., Pizarro F., Barahona M. (1991) Comparison of two flexible drug schedules for panic . American Psychiatric Association 144th Annual Meeting, New research program and abstracts, NR381, p. 139
19.
Graeff F.G. (1988) Animal models of aversion. In Simon P, Soubrié P, Widlocher D (eds), Selected models of anxiety, depression and psychosis. Animal models of psychiatric disorders, vol. 1., Karger, Basel, pp. 115-141
20.
Guelfi J.D., Bobon D. (1989) Echelles d'evaluation en psychiatrie. In Encyclopédie médico-chirurgicale, psychiatrie, 37200: A10.10
21.
Guy W. ( 1976) ECDEU assessment manual for psychopharmacology, revised . NIMH Publishers, DHEW Publ. nr. (Adm.), 76/338, pp. 217-222
22.
Hamilton M. (1960) A rating scale for depression. J Neurol Neurosurg Psychiatr23: 56-62
23.
Harding T. (1973) Clomipramine (Anafranil) in agoraphobia. J Int Med Res1: 425
24.
Healy D. (1990) The psychopharmacological era: notes toward a history . J Psychopharmacol4: 152-167
25.
Healy D. (1991) The marketing of 5-hydroxytryptamine: depression or anxiety? Br J Psychiatr158: 737-742
26.
Hughes J.R., Krahn D. (1985) Blindness and the validity of the double-blind procedure. J Clin Psychopharmacol5: 138-142
27.
Huzoláková I., Dukes M N G (1984) Drugs affecting autonomic functions or the extrapyramidal system. In Dukes M N G (ed.), Meyler's side effects of drugs. 10th edn, Elsevier, Amsterdam, pp. 232-253
28.
Jenicke M.A., Hyman S., Baer L., Holland A., Minichiello W.E., Buttol P.H., Summergrad P., Seymour R., Ricciardi J. (1990) A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Am J Psychiatr147: 1209-1215
29.
Johnston D.G., Troyer I.E., Whitsett S.E. (1988) Clomipramine treatment of agoraphobic women. An eight-week controlled trial. Arch Gen Psychiatr45: 453-459
30.
Kahn R.S., Westenberg H G M, Verhoeven W M A, Gispen-DeWied C.C., Kamerbeek W D J (1987) Effect of a serotonin precursor and uptake inhibitor in anxiety disorders: a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Clin Psychopharmacol2: 33-45
31.
Kahn R.S., van Praag H.M., Wetzler S., Asnis G.M., Barr G. ( 1988) Serotonin and anxiety revisited. Biol Psychiatr23: 189-208
32.
Klein D.F. (1964) The delineation of two drug-responsive anxiety syndromes. Psychopharmacologia5: 397-408
33.
Loebel A.D., Hyde T.S., Dunner D.L. (1986) Early placebo response in anxious and depressed patients. J Clin Psychiatr47: 230-233
34.
Lydiard R.B., Ballenger J.C. (1987) Antidepressants in panic disorder and agoraphobia . J Affective Disord13: 153-168
35.
Marks I.M., Gray S.G., Cohen D., Hill R., Mawson D., Ramm E., Stern R.S. (1983) Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework. Arch Gen Psychiatr40: 153-162
36.
Marks I.M., De Albuquerque A., Cottraux J., Gentil V., Greist J., Hand I., Liberman R.L., Relvas J.S., Tobeña A., Tyrer P., Wittchen H.U. (1989) The "efficacy" of alprazolam in panic disorder and agoraphobia: a critique of recent reports. Arch Gen Psychiatr (letter) 46: 668-670
37.
Mavissakalian M. (1987) The placebo effect in agoraphobia. J Nerv Ment Dis175: 95-99
38.
Mavissakalian M., Perel J. (1985) Imipramine in the treatment of agoraphobia: dose response relationships. Am J Psychiatr142: 1032-1036
39.
Mavissakalian M., Perel J. (1989) Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings. Arch Gen Psychiatr46: 127-131
40.
Modigh K. (1987) Antidepressant drugs in anxiety disorders. Acta Psychiatr Scand76(Suppl 335): 57-74
41.
Modigh K., Westberg P., Eriksson E. (1992) Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo controlled trial. J Clin Psychopharmacol12: 251-261
42.
Noyes R., Garvey M.J., Cook B.L., Samuelson L. (1989) Problems with tricyclic antidepressants use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study. J Clin Psychiatr50: 163-169
43.
Paykel E.S. (1987) Depression, anxiety and antidepressant response . In Racagni G, Smeraldi E (eds), Anxious depression: assessment and treatment . Raven Press, New York, pp. 171-180
44.
Pohl R., Balon R., Yeragani V.K., Gershon S. (1989) Serotonergic anxiolytics in the treatment of panic disorder. A controlled study with buspirone. Psychopathology22(suppl. 1): 60-67
45.
Rodin G., Voshart K. (1986) Depression in the medically ill: an overview. Am J Psychiatr143: 696-705
46.
Wetzler S., Katz M.M. (1989) Problems with the differentiation of anxiety and depression. J Psychiatr Res23: 1-12
47.
Winer B.J. (1971) Statistical principles in experimental designs . 2nd edn. McGraw-Hill, New York
48.
Winokur G. (1990) The concept of secondary depression. In Wesner R B, Winokur G (eds), Anxiety and depression as secondary phenomena. Psychiatr Clin North Am13: 567-583
